OTC Labeling: FDA "Sensitive" To UPC Code Issues, Agency's Bowen Says
This article was originally published in The Rose Sheet
FDA is considering omitting the space needed for a properly sized Uniform Product Code symbol from the calculation of whether an OTC package is exempt from the type size requirements of the OTC labeling final rule, FDA ODE V Deputy Director Debra Bowen, MD, and Division of OTC Drugs Director Charles Ganley, MD, said at an OTC labeling "feedback" meeting in Rockville, Md. June 29.
You may also be interested in...
FDA is allowing a modified labeling format for product packages too small to conform to the agency's content and format requirements under the OTC drug labeling final rule. The adjustments also apply to unusually shaped packages. The much-anticipated rule was announced by Vice President Gore March 11 and is slated for publication in the Federal Register March 17.
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle